๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A tissue sealant based on reactive multifunctional polyethylene glycol

โœ Scribed by Wallace, D. G. ;Cruise, G. M. ;Rhee, W. M. ;Schroeder, J. A. ;Prior, J. J. ;Ju, J. ;Maroney, M. ;Duronio, J. ;Ngo, M. H. ;Estridge, T. ;Coker, G. C.


Book ID
102293619
Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
306 KB
Volume
58
Category
Article
ISSN
0021-9304

No coin nor oath required. For personal study only.

โœฆ Synopsis


A rapidly gelling synthetic tissue sealant was developed from tetra-succinimidyl and tetra-thiol-derivatized polyethylene glycol (PEG). The two reagents were dissolved in aqueous buffers at 20% (w/v) solids and sprayed on the tissue site, with the use of a sprayer/mixer device. Good adhesion to collagen membranes, PTFE grafts, and carotid artery was observed in vitro. In a burst test on collagen membranes with a 2-mm orifice defect, the gel sustained fluid pressures of 125 +/- 36 mm Hg (n = 18), fivefold greater than capillary blood pressure and one-half that observed in hypertension. On 0.4-mm-diameter puncture defects in PTFE grafts, pressures of 390-490 mm Hg were sustained, and on 0.6-0.9-mm puncture defects in carotid arteries, pressures of 490 to 840 mm Hg were sustained. In vitro data corresponded to results in vivo, where bleeding in rabbit arteries was stopped immediately in five out of six trials. A significant reduction in time to hemostasis and blood loss, compared to controls, was observed. Carotid artery and subcutaneous implant data in rabbits showed that the formula was compatible with biological tissue. Rapid gelling and effective sealing were dependent on the presence of active succinimidyl ester and thiol groups on PEG. HPLC and chemical substitution methods were useful in predicting whether batches of derivatized PEG would perform satisfactorily.


๐Ÿ“œ SIMILAR VOLUMES


Silk fibroin and polyethylene glycol-bas
โœ Monica A. Serban; Bruce Panilaitis; David L. Kaplan ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 728 KB

## Abstract Tissue sealants have emerged in recent years as strong candidates for hemostasis. A variety of formulations are currently commercially available and though they satisfy many of the markets' needs there are still key aspects of each that need improvement. Here we present a new class of b